Vitamin Shoppe Inc. (NYSE:VSI)’s share price was up 1.6% during trading on Tuesday . The company traded as high as $28.16 and last traded at $27.97, with a volume of 211,912 shares traded. The stock had previously closed at $27.54.

A number of equities analysts have recently commented on VSI shares. Zacks Investment Research downgraded Vitamin Shoppe from a “hold” rating to a “sell” rating in a research report on Wednesday, April 20th. Wedbush started coverage on Vitamin Shoppe in a research report on Wednesday, April 20th. They set an “outperform” rating and a $39.00 price objective for the company. Robert W. Baird reissued a “hold” rating on shares of Vitamin Shoppe in a research report on Tuesday, April 26th. Goldman Sachs Group Inc. downgraded Vitamin Shoppe to a “hold” rating in a report on Saturday, April 30th. Finally, Macquarie reaffirmed a “neutral” rating and issued a $40.00 price target on shares of Vitamin Shoppe in a report on Thursday, May 5th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company. Vitamin Shoppe has an average rating of “Hold” and an average price target of $32.82.

The stock has a market capitalization of $672.38 million and a P/E ratio of 16.70. The firm’s 50 day moving average price is $29.87 and its 200 day moving average price is $29.77.

Vitamin Shoppe (NYSE:VSI) last released its quarterly earnings data on Wednesday, August 3rd. The company reported $0.55 EPS for the quarter, missing analysts’ consensus estimates of $0.59 by $0.04. The firm earned $332.70 million during the quarter, compared to the consensus estimate of $331.58 million. Vitamin Shoppe’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter last year, the business posted $0.57 EPS. On average, equities analysts expect that Vitamin Shoppe Inc. will post $2.17 EPS for the current year.

In related news, Director Guillermo Marmol bought 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 31st. The shares were acquired at an average cost of $30.23 per share, for a total transaction of $30,230.00. Following the acquisition, the director now owns 1,470 shares in the company, valued at approximately $44,438.10. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link.

A hedge fund recently raised its stake in Vitamin Shoppe stock. Rhumbline Advisers increased its stake in shares of Vitamin Shoppe Inc. (NYSE:VSI) by 4.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 45,118 shares of the company’s stock after buying an additional 1,855 shares during the period. Rhumbline Advisers owned 0.16% of Vitamin Shoppe worth $1,475,000 as of its most recent filing with the SEC.

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, which includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats; direct, which sells its products directly to consumers through the Internet, primarily at, and manufacturing, which provides custom manufacturing and private labeling of vitamin, mineral and supplement (VMS) products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.